Lung Cancer
News
ELCC: NSCLC mutation testing highlights ctDNA’s limitations
Key clinical point: In a real-world setting genetic tests that used ctDNA to find treatment-determining mutations in patients with advanced lung...
News
AACR: KEYNOTE-001 takes step toward PD-L1 blocker biomarker
Key clinical point: Pembrolizumab provided durable responses in NSCLC, with clinical outcomes correlating with a proposed biomarker. Major finding...
Case Reports
Sarcoidosis, complete heart block, and warm autoimmune hemolytic anemia in a young woman
News
Three-dimensional models show superiority of nanoparticles in mesothelioma
Key clinical point: Three-dimensional spheroid models, as opposed to monolayer cell cultures, are valuable tools for predicting the efficacy of...
Video
VIDEO: Circulating tumor DNA testing shows real-world limits
News
Advanced NSCLC responds to nivolumab
Key clinical point: Nivolumab monotherapy for advanced, heavily pretreated non–small cell lung cancer (NSCLC) generated outcomes that surpassed...
News
TKI benefit greater with certain EGFR mutations in NSCLC tumors
Key clinical point: Risk of non–small cell lung cancer (NSCLC) progression is reduced by 63% for patients with epidermal growth factor receptor (...
Video
VIDEO: TKIs merit broader use as NSCLC adjuvant
Reviews
Sleep disorders in patients with cancer
News
No significant survival gains with granulocyte colony-stimulating factor
Key clinical point: Treatment with granulocyte colony-stimulating factor during chemotherapy does not significantly impact overall survival. Major...
News
Palliative surgery eases pain at end of life
Key clinical point: Palliative surgery in patients with advanced cancers can relieve pain with minimal morbidity. Major finding: Pain scores...